These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9509960)

  • 1. Skin reactions with transdermal estradiol therapy in a tropical environment.
    Bhathena RK; Anklesaria BS; Ganatra AM
    Int J Gynaecol Obstet; 1998 Feb; 60(2):177-9. PubMed ID: 9509960
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin reactions to transdermal estrogen replacement therapy in a tropical climate.
    de Cetina TC; Reyes LP
    Int J Gynaecol Obstet; 1999 Jan; 64(1):71-2. PubMed ID: 10190675
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of two types of estradiol-releasing skin patches for menopausal patients in a tropical climate.
    McCarthy T; Dramusic V; Ratnam S
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):2005-10. PubMed ID: 1605292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women.
    Sentrakul P; Chompootaweep S; Sintupak S; Tasanapradit P; Tunsaringkarn K; Dusitsin N
    Maturitas; 1991 Jun; 13(2):151-4. PubMed ID: 1833610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an objective method of determining skin erythema to transdermal oestradiol patches.
    Ross D; Whitehead M; Pike B
    Br J Obstet Gynaecol; 1999 Mar; 106(3):279-83. PubMed ID: 10426650
    [No Abstract]   [Full Text] [Related]  

  • 6. Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate.
    Frenkel Y; Kopernik G; Lazer S; Tugendreich D; Zmira N; Oettinger M; Tendler R; Serr DM
    Maturitas; 1994 Nov; 20(1):31-6. PubMed ID: 7877518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal estrogen therapy.
    Connell EB
    Postgrad Med; 1997 Jun; 101(6):115-6, 122, 128-30 passim. PubMed ID: 9194869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised crossover comparison of skin irritation with two transdermal oestradiol patches.
    Ross D; Rees M; Godfree V; Cooper A; Hart D; Kingsland C; Whitehead M
    BMJ; 1997 Aug; 315(7103):288. PubMed ID: 9274549
    [No Abstract]   [Full Text] [Related]  

  • 10. Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally.
    Boehncke WH; Gall H
    Contact Dermatitis; 1996 Sep; 35(3):187-8. PubMed ID: 8930492
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura and 17 beta-estradiol transdermal skin patch.
    Liang R; Wong RW; Cheng IK
    Am J Hematol; 1996 Aug; 52(4):334-5. PubMed ID: 8701965
    [No Abstract]   [Full Text] [Related]  

  • 12. An Australian experience of transdermal oestradiol patches in a subtropical climate.
    O'Neill S; Kirkegard Y
    Aust N Z J Obstet Gynaecol; 1993 Aug; 33(3):327-9. PubMed ID: 8304906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis.
    Bertonazzi A; Nelson B; Salvador J; Umland E
    Womens Health (Lond); 2015 Nov; 11(6):815-24. PubMed ID: 26618621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy - less is often more].
    Schneider HP
    Zentralbl Gynakol; 2001 Sep; 123(9):546-7. PubMed ID: 11709750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerability.
    Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J; Thebault J
    Maturitas; 1996 Nov; 25(3):175-85. PubMed ID: 8981334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis from estradiol in a transdermal therapeutic system.
    Quirce S; Garde A; Baz G; Gonzalez P; Alonso Diaz de Durana MD
    Allergy; 1996 Jan; 51(1):62-3. PubMed ID: 8721533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone.
    Mueck AO
    Climacteric; 2012 Apr; 15 Suppl 1():11-7. PubMed ID: 22432811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.